[ad_1] By Deborah Bell, executive director of business development in Australia, Avania Whether to control costs or to recruit a larger population, medical device manufacturers are looking beyond the U.S., the EU, and Asia to conduct clinical trials. When planning global studies and early commercialization, Australia is a strongly considered market. The access to innovative